1990—2019年中国人类免疫缺陷病毒/获得性免疫缺陷综合征流行趋势及疾病负担

doi:10.6040/j.issn.1671-7554.0.2022.1204

摘要/Abstract

摘要： 目的分析1990—2019年中国人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)疾病流行现状、负担及危险因素变化趋势,预测2020—2030年HIV/AIDS发病和死亡情况。方法探讨1990—2019年中国HIV/AIDS疾病的流行现状,通过Joinpoint回归拟合其发病率和疾病负担变化趋势。采用集成嵌套拉普拉斯近似(INLA)的贝叶斯年龄-时期-队列分析(BAPC)方法预测2020—2030年HIV/AIDS发病和死亡趋势。结果 1990—2019年中国男性HIV/AIDS标化发病率、标化死亡率高于女性,15~19岁、20~24岁标化发病率总体呈增长趋势,75~79岁标化发病率变化幅度最大。1990—2019年中国HIV/AIDS标化发病率、标化伤残调整寿命年(DALYs)率均呈上升趋势,差异具有统计学意义(P均<0.001);归因于危险性行为的标化DALYs率最高。BAPC预测结果显示,2020—2030年中国男性HIV/AIDS标化死亡率呈上升趋势。结论中国青少年HIV/AIDS发病风险持续增加,老年群体死亡风险也不容忽视;HIV/AIDS疾病负担呈上升趋势,危险性行为是首要危险因素。未来应针对重点人群采取预防和控制措施。

关键词: 人类免疫缺陷病毒/获得性免疫缺陷综合征, 疾病负担, 危险因素, 时间趋势, 预测

Abstract: Objective To analyze the situation, disease burden and risk factors of human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)in China from 1990 to 2019 and to forecast the incidence and mortality from 2020 to 2030. Methods The situation of HIV/AIDS in China from 1990 to 2019 was explored and its temporal trend of incidence and disease burden were analyzed with Joinpoint regression. The trend of incidence and mortality from 2020 to 2030 were predicted with Bayesian age-period-cohort(BAPC)model integrated with nested Laplace approximations. Results The age-standardized incidence and mortality rate of HIV/AIDS in China in males were higher than those in females. The age-standardized incidence showed an increasing trend in people aged 15 to 19 years and 20 to 24 years, and showed the largest variation in people aged 75 to 79 years. The age-standardized incidence and disability-adjusted life years(DALYs)rate of HIV/AIDS in China increased from 1990 to 2019 and there were statistically significant differences(P<0.001); the age-standardized DALYs rate of HIV/AIDS attributable to unsafe sex was the highest. The BAPC predicted that the age-standardized mortality rate of HIV/AIDS in China in males would increase from 2020 to 2030. Conclusion The risk of HIV/AIDS incidence in adolescents continues to increase in China and the risk of mortality in elderly should not be ignored. The disease burden of HIV/AIDS shows an increasing trend and unsafe sex is the primary risk factor. In the future, prevention and control measures should be taken for the key population.

Key words: Human immunodeficiency virus/acquired immunodeficiency syndrome, Disease burden, Risk factors, Temporal trend, Prediction

中图分类号:

R181.2

张蒙,马伟. 1990—2019年中国人类免疫缺陷病毒/获得性免疫缺陷综合征流行趋势及疾病负担[J]. 山东大学学报 (医学版), 2023, 61(5): 84-89.

ZHANG Meng, MA Wei. Trend and disease burden of human immunodeficiency virus/acquired immunodeficiency syndrome in China from 1990 to 2019[J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 84-89.

参考文献

[1] Xu JJ, Han MJ, Jiang YJ, et al. Prevention and control of HIV/AIDS in China: lessons from the past three decades[J]. Chin Med J(Engl), 2021, 134(23): 2799-2809.
[2] GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017[J]. Lancet HIV, 2019, 6(12): e831-e859.
[3] 赵虹琳, 李巧梅, 李婷婷, 等. 2004—2018年中国艾滋病发病与死亡趋势及其年龄-时期-队列模型分析 [J]. 中国全科医学, 2023, 26(4): 409-416. ZHAO Honglin,LI Qiaomei,LI Tingting,et al. AIDS in China from 2004 to 2018:incidence and mortality trends and age-period-cohort effect analysis[J]. Chinese General Practice, 2023, 26(4): 409-416.
[4] Qiao YC, Xu Y, Jiang DX, et al. Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004-2016[J]. Int J Infect Dis, 2019, 81: 215-20. doi: 10.1016/j.ijid.2019.02.016.
[5] Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019[J]. Lancet, 2020, 396(10258): 1204-1222.
[6] Jahagirdar D, Walters MK, Novotney A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the global burden of diseases study 2019[J]. Lancet HIV, 2021, 8(10): e633-e651.
[7] Hu W, Fang L, Zhang H, et al. Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China[J]. Public Health, 2022, 208: 89-97. doi: 10.1016/j.puhe.2022.04.015.
[8] Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the global burden of disease study[J]. Lancet, 2017, 390(10100): 1460-1464.
[9] Ma Y, Cui Y, Hu Q, et al. Long-term changes of HIV/AIDS incidence rate in China and the U.S. population from 1994 to 2019: a join-point and age-period-cohort analysis[J]. Front Public Health, 2021, 9: 652868. doi: 10.3389/fpubh.2021.652868.
[10] Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019[J]. Lancet, 2020, 396(10258): 1223-1249.
[11] Centers for disease control and prevention. Fast facts: preventing intimate partner violence [EB/OL].(2022-10-11)[2022-11-14]. https://www.cdc.gov/violenceprevention/inti-matepartnerviolence/fastfact.html.
[12] Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.
[13] Riebler A, Held L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested LaPlace approximations[J]. Biom J, 2017, 59(3): 531-549.
[14] Wang X, Wang Z, Jiang X, et al. A cross-sectional study of the relationship between sexual compulsivity and unprotected anal intercourse among men who have sex with men in shanghai, China[J]. BMC Infect Dis, 2018, 18(1): 465. doi: 10.1186/s12879-018-3360-x.
[15] Zhong F, Lin P, Xu H, et al. Possible increase in HIV and syphilis prevalence among men who have sex with men in Guangzhou, China: results from a respondent-driven sampling survey[J]. AIDS Behav, 2011, 15(5): 1058-1066.
[16] Bor J, Rosen S, Chimbindi N, et al. Mass HIV treatment and sex disparities in life expectancy: demographic surveillance in rural South Africa[J]. PLoS Med, 2015, 12(11): e1001905. doi: 10.1371/journal.pmed.1001905.
[17] Takarinda KC, Harries AD, Shiraishi RW, et al. Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010[J]. Int J Infect Dis, 2015, 30: 98-105. doi: 10.1016/j.ijid.2014.11.009.
[18] Trepka MJ, Fennie KP, Sheehan DM, et al. Late HIV diagnosis: differences by rural/urban residence, Florida, 2007-2011[J]. AIDS Patient Care STDS, 2014, 28(4): 188-197.
[19] Zhao H, Liu H, Wang L, et al. Epidemiological characteristics of newly-reported HIV cases among youth aged 15-24 Years-China, 2010-2019[J]. China CDC Wkly, 2020, 2(48): 913-916.
[20] 郭伟贵, 茅乃玲, 沈智勇. 学校艾滋病防控面临的挑战及策略[J]. 实用预防医学, 2020, 27(11): 1403-1405. GUO Weigui, MAO Nailing, CHEN Zhiyong. Challenges and strategies for HIV/AIDS prevention and control in schools[J]. Practical Preventive Medicine, 2020, 27(11):1403-1405.
[21] 刘童童, 陈清峰, 李雨波, 等. 艾滋病防治宣传教育实践与挑战[J]. 中国艾滋病性病, 2021, 27(11): 1179-1181.
[22] 张静, 谢今朝, 刘聪, 等. 2004—2019年广州市艾滋病抗病毒治疗老年患者特征变化趋势: 基于Joinpoint回归的回顾性队列研究[J]. 现代预防医学, 2021, 48(12): 2276-2280. ZHANG Jing, XIE Jinzhao, LIU Cong, et al. Joinpoint regression model analysis on trend characteristics among HIV-infected patients starting antiretroviral treatment in Guangzhou 2004-2019[J]. Modern Preventive Medicine, 2021, 48(12): 2276-2280.
[23] Montano M, Landay A, Perkins M, et al. HIV and aging in the era of ART and COVID-19: symposium overview[J]. J Acquir Immune Defic Syndr, 2022, 89(Suppl 1): s3-s9.
[24] Sun X, Lu F, Wu Z, et al. Evolution of information-driven HIV/AIDS policies in China[J]. Int J Epidemiol, 2010, 39(Suppl 2): ii4-ii13.
[25] Mao Y, Wu Z, Poundstone K, et al. Development of a unified web-based national HIV/AIDS information system in China[J]. Int J Epidemiol, 2010, 39(Suppl 2): ii79-ii89.
[26] 郑灵巧, 陈清峰, 沈洁. 中国艾滋病防治政策与策略发展历程回溯[J]. 中国艾滋病性病, 2019, 25(7): 657-661.
[27] Wang L, Wang L, Norris JL, et al. HIV prevalence and influencing factors analysis of sentinel surveillance among men who have sex with men in China, 2003-2011[J]. Chin Med J(Engl), 2012, 125(11): 1857-1861.
[28] 胡健. 青年男同性恋/双性恋者多性伴行为的社会文化因素[J]. 中国艾滋病性病, 2020, 26(2): 172-174. HU Jian. Sociocultural factors of sexual behaviors with multiple sex partners among young homosexual/bisexual men[J]. Chinese Journal of AIDS & STD, 2020, 26(2): 172-174.
[29] Bao YP, Liu ZM, Li JH, et al. Club drug use and associated high-risk sexual behaviour in six provinces in China[J]. Addiction, 2015, 110(Suppl 1): 11-19.
[30] 韩孟杰, 陈清峰, 徐鹏, 等. 砥砺奋进“十三五”艾滋病防控迈向新征程—我国艾滋病防治回顾与展望[J]. 中国艾滋病性病, 2021, 27(12): 1327-1331.
[31] Hampanda KM, Rael CT. HIV status disclosure among postpartum women in Zambia with varied intimate partner violence experiences[J]. AIDS Behav, 2018, 22(5): 1652-1661.
[32] Su X, Zheng L, Zhang H, et al. Secular trends of acute viral hepatitis incidence and mortality in China, 1990 to 2019 and its prediction to 2030: the global burden of disease study 2019[J]. Front Med(Lausanne), 2022, 9: 842088. doi: 10.3389/fmed.2022.842088.

相关文章 15

[1]	王烨,王刚,南海鸥,蔡雨玲,李嘉宇,王海锋,颜英杰,江志伟. 胃癌患者围手术期心率变异度与炎性指标的相关性[J]. 山东大学学报 (医学版), 2026, 64(4): 23-30.
[2]	段盈竹,董波,于睿. 内在情感与类风湿关节炎患者冠状动脉粥样硬化风险关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2026, 64(4): 63-71.
[3]	黄玉真,吕琛,颜磊,李帅帅,张景雪,刘超,王银霞,桑岩岩,房鹛. 基于危险因素筛查的延续性院外管理对卵巢过度刺激综合征的预防效果[J]. 山东大学学报 (医学版), 2026, 64(4): 92-99.
[4]	王建民,李晓峰,由志涛,董圣杰,赵宇驰,李占菊,邹德鑫,张剑锋,孙涛,杜伟. 基于可解释机器学习的后路腰椎椎体间融合术后慢性疼痛风险预测模型构建[J]. 山东大学学报 (医学版), 2026, 64(2): 78-88.
[5]	逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19.
[6]	孙爽爽,仉率杰,张伯韬,袁莹,于媛媛,薛付忠. 基于真实世界研究的18~50岁人群急性缺血性卒中影响因素[J]. 山东大学学报 (医学版), 2025, 63(9): 40-46.
[7]	王梦星,薛付忠,杨帆. 基于多模态交叉注意力机制融合的1型糖尿病血糖浓度预测方法[J]. 山东大学学报 (医学版), 2025, 63(8): 41-50.
[8]	申路佳,逯天威,巩伟明,赵岩松,王淑康,袁中尚. 代谢风险评分在2型糖尿病人群心血管结局预测中的应用[J]. 山东大学学报 (医学版), 2025, 63(8): 69-78.
[9]	李千,杨帆,薛付忠. 基于多模态数据融合的多癌种风险预测模型[J]. 山东大学学报 (医学版), 2025, 63(8): 79-85.
[10]	李晓琪,刘佩丽,成红,赵艳艳. 基于自注意力机制预测ICU脓毒症患者的死亡率[J]. 山东大学学报 (医学版), 2025, 63(8): 86-93.
[11]	陈莹莹,王鲁,胡锡峰,朱高培,薛付忠. 基于贝叶斯网络的2型糖尿病患者并发脑卒中风险预测[J]. 山东大学学报 (医学版), 2025, 63(8): 94-102.
[12]	张政,王建伟,杨玉娟,张宇,宋西成. 哮喘儿童2008及2019年免疫球蛋白E变化及相关危险因素[J]. 山东大学学报 (医学版), 2025, 63(7): 32-36.
[13]	王丽云,高天勤,刘雨佳,陈青,陈柳,沙凯辉. 基于机器学习产后压力性尿失禁风险预测模型的构建及验证[J]. 山东大学学报 (医学版), 2025, 63(6): 55-66.
[14]	杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[15]	陈瑛翼,游倩,王意,张帆,李凤,季舒铭,徐浩源,饶志勇. 办公室职员肌肉质量减少预测模型的开发与验证[J]. 山东大学学报 (医学版), 2025, 63(4): 26-35.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed